These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22509368)

  • 21. Induction of SOX4 by DNA damage is critical for p53 stabilization and function.
    Pan X; Zhao J; Zhang WN; Li HY; Mu R; Zhou T; Zhang HY; Gong WL; Yu M; Man JH; Zhang PJ; Li AL; Zhang XM
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3788-93. PubMed ID: 19234109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
    Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes.
    Jetten AM; Kurebayashi S; Ueda E
    Prog Nucleic Acid Res Mol Biol; 2001; 69():205-47. PubMed ID: 11550795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes.
    Solt LA; Banerjee S; Campbell S; Kamenecka TM; Burris TP
    Endocrinology; 2015 Mar; 156(3):869-81. PubMed ID: 25560829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.
    Andrews A; Warner K; Rodriguez-Ramirez C; Pearson AT; Nör F; Zhang Z; Kerk S; Kulkarni A; Helman JI; Brenner JC; Wicha MS; Wang S; Nör JE
    Clin Cancer Res; 2019 Mar; 25(5):1588-1600. PubMed ID: 30498096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12.
    Roubalová E; Kvardová V; Hrstka R; Borilová S; Michalová E; Dubská L; Müller P; Sova P; Vojtesek B
    Invest New Drugs; 2010 Aug; 28(4):445-53. PubMed ID: 19499188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
    Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
    Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles.
    Asharani PV; Xinyi N; Hande MP; Valiyaveettil S
    Nanomedicine (Lond); 2010 Jan; 5(1):51-64. PubMed ID: 20025464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
    Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
    Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
    Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S
    Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors.
    Henze J; Mühlenberg T; Simon S; Grabellus F; Rubin B; Taeger G; Schuler M; Treckmann J; Debiec-Rychter M; Taguchi T; Fletcher JA; Bauer S
    PLoS One; 2012; 7(5):e37776. PubMed ID: 22662219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear receptor retinoid-related orphan receptor alpha promotes apoptosis but is reduced in human gastric cancer.
    Wang Z; Xiong F; Wang X; Qi Y; Yu H; Zhu Y; Zhu H
    Oncotarget; 2017 Feb; 8(7):11105-11113. PubMed ID: 28052040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
    Knutson AK; Welsh J; Taylor T; Roy S; Wang WL; Tenniswood M
    Oncol Rep; 2012 Mar; 27(3):849-53. PubMed ID: 22159450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of PDCD5 effect on the biological behavior of tumor cells and sensitized gastric cancer cells to cisplatin-induced apoptosis.
    Xu HY; Chen ZW; Pan YM; Fan L; Guan J; Lu YY
    Dig Dis Sci; 2012 Jul; 57(7):1847-56. PubMed ID: 22359193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of IKKbeta activity increases p53 stability and p21 expression leading to cell cycle arrest and apoptosis.
    Yang PM; Huang WC; Lin YC; Huang WY; Wu HA; Chen WL; Chang YF; Chou CW; Tzeng CC; Chen YL; Chen CC
    J Cell Mol Med; 2010 Mar; 14(3):687-98. PubMed ID: 19243472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells.
    Gogna R; Madan E; Keppler B; Pati U
    Br J Pharmacol; 2012 May; 166(2):617-36. PubMed ID: 22074401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of apoptosis by pyrazolo[3,4-d]pyridazine derivative in lung cancer cells via disruption of Bcl-2/Bax expression balance.
    Mohamed MS; Abdelhamid AO; Almutairi FM; Ali AG; Bishr MK
    Bioorg Med Chem; 2018 Feb; 26(3):623-629. PubMed ID: 29290491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model.
    Elsayed AM; Sherif NM; Hassan NS; Althobaiti F; Hanafy NAN; Sahyon HA
    Int J Biol Macromol; 2021 Aug; 185():134-152. PubMed ID: 34147524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.